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Summary
 Background Pulsed dose rate (PDR) brachytherapy is clinically used as an irradiation tech-
nique. It combines the physical advantages of high-dose-rate (HDR) technology 
(isodose optimization, planning ﬂ exibility and radiation safety) with the radio-
biological advantages of low-dose-rate (LDR) brachytherapy [1,2]. The single ra-
dioactive stepping source moves through all the implanted catheters during each 
pulse. The source is enclosed in a capsule 2.5mm long with a diameter of 1.1mm 
[3]. The resulting isodoses can be optimized by modulating the dwell time of the 
source as a function of its trajectory within the implanted volume.
 Aim The aim of this study was the dosimetric veriﬁ cation (in-phantom) of doses calcu-
lated with the Plato treatment planning system (TPS) by using GafChromic ﬁ lms 
and thermoluminescent detectors (TL) in PDR brachytherapy.
 Materials/Methods Absorbed doses at chosen points were measured with TL detectors, while dose 
distributions were measured with GafChromic ﬁ lms. Dose measurements were 
made at 14 reference points in a specially designed, tissue equivalent phantom. 
The prescribed doses were compared with the measured doses. A fusion of two 
dose distributions was made. The image read from the dosimetric ﬁ lm after its 
digitalization was fused with the one received from TPS. Qualitative analysis of 
this fusion was performed.
 Results Wilcoxon test and sign test (dependent samples) were used to compare the dos-
es calculated with those measured with TL detectors. The statistical comparison 
of doses calculated and measured revealed differences in the range of – 14.7% 
to 12.6%. These results ﬁ tted well with the results of qualitative analysis made us-
ing images’ fusion made for calculated and measured dose distributions.
 Conclusions Both quantitative and qualitative analysis proved the correctness of the calcula-
tion algorithms used by the Plato planning system in a phantom study for PDR 
brachytherapy.
 Key words PDR brachytherapy • dose veriﬁ cation • dose measurements • thermoluminescent 
dosimetry • GafChromic ﬁ lm
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BACKGROUND
Pulsed dose rate (PDR) brachytherapy is clinical-
ly used as an irradiation technique. It combines 
the physical advantages of high-dose-rate (HDR) 
technology (isodose optimization, planning ﬂ ex-
ibility and radiation safety) with the radiobiologi-
cal advantages of low-dose-rate (LDR) brachyther-
apy [1,2]. The single radioactive stepping source 
moves through all the implanted catheters during 
each pulse. The source is enclosed in a capsule 
2.5mm long with a diameter of 1.1mm [3]. The 
resulting isodoses can be optimized by modulat-
ing the dwell time of the source as a function of 
its trajectory within the implanted volume.
In our radiotherapy department about 15% of 
all radiotherapy patients are treated with brachy-
therapy. Pulsed dose rate (PDR) brachytherapy is 
used to treat many types of cancer. A typical treat-
ment in which PDR brachytherapy may be used 
is, for example, the treatment of cancer of the 
cervix. Radioactive sources are placed in or near 
the tumour itself, giving a high radiation dose to 
the tumour while reducing the radiation expo-
sure in the surrounding healthy tissues. Various 
applicators are in use to hold the sources in an 
appropriate conﬁ guration. A cervix applicator 
consists of a central tube (tandem) and lateral 
capsules (ovoids). In remote afterloading devices 
Ir192 is used as a radioactive source [3–5].
AIM
The aim of this paper was the dosimetric veriﬁ -
cation (in-phantom) of calculated dose distribu-
tion by the Plato treatment planning system in 
PDR brachytherapy using GafChromic ﬁ lms and 
thermoluminescent detectors (TLD).
MATERIALS AND METHODS
Doses were measured with thermolumines-
cent (TL) detectors [6–8]. TLD-100 detectors 
(3.0×3.0×0.9mm3) made of LiF and a Harshaw 
3500 TLD Reader were used.
Pre-irradiation annealing was carried out at 400°C 
for 1h, then at 100°C for 4h followed by cooling 
to room temperature. The detectors were read 
out at 260°C. TL dosimeters were calibrated in 
a Co-60 beam [7]. Calibration was carried out in 
a PMMA phantom with 5mm build-up in a ho-
mogeneous ﬁ eld 20×20cm2. Stability of the de-
tectors was within 3%.
Dose distributions were measured with 
GafChromic MD-55 ﬁ lms [8,9]. The ﬁ lm was 
placed between the two pieces of phantom, par-
allel to the catheter axis. Images obtained on the 
basis of the dosimetric ﬁ lms were digitalized in 
24 bit colour scale. Then they were analyzed us-
ing the Origin v.7 application. The ﬁ lms used in 
this study were not calibrated. Therefore dose 
distributions obtained using radiochromic ﬁ lms 
were digitalized and used only for visual com-
parison with the dose distributions, which were 
calculated using Plato v.14.1.3 by the Nucletron 
treatment planning system.
The measurements were performed in the tissue 
equivalent phantom designed by the authors. The 
phantom consisted of two parts, which were con-
nected. A hole was drilled in the middle of the 
boundary between the parts in which the source 
was input. Both parts had the shape of rectangu-
lar prisms (30×22×6cm3) and were made of al-
loy of a wax and parafﬁ n mixture. The catheter 
was inserted into the hole. A total of 14 TL-de-
tectors were placed in the selected dosimetric 
points and GafChromic ﬁ lm was placed between 
the two pieces of phantom. The phantom used 
in the study is shown in Figure 1.
The brachytherapy treatment plan was calculated 
in the Plato planning system. 14 reference points 
were determined. The Integrated Brachytherapy 
Unit (IBU) was used to verify the positions of the 
applicator and detectors [10]. The treatment 
plan was made on the basis of received images, 
shown in Figure 2. The distance between consec-
utive dwell points was 2.5mm; however, distance 
between reference points was 5.0mm. The dose 
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was given with a microSelectron PDR afterload-
ing unit (Nucletron).
The prescribed doses were compared with the 
measured doses. Wilcoxon test and sign test (de-
pendent samples, conﬁ dence level 95%) were 
used to compare the prescribed doses (calculat-
ed by TPS) with doses measured by thermolumi-
nescent detectors [7,11–13].
The fusion of images with dose distributions was 
made. The image read from the dosimetric ﬁ lm 
after its digitalization was fused with the one re-
ceived from TPS. Qualitative analysis of this fu-
sion was performed.
RESULTS
Four series of measurements were made. Results of 
doses measured using thermoluminescent detec-
tors (Dm1,…, Dm4) are shown in Table 1. The sym-
bol “–” means that the result of the measurement 
was rejected because of major error. The rejec-
tion was made when the result was more than the 
standard deviation multiplied by 3 (Dm>3SD).
Table 2 shows mean measured doses (
_
Dm) and cal-
culated doses (Dc) by TPS for each reference point. 
The TPS calculation error (ΔDc) is about 5%. 
However/Additionally, for each of the measured 
doses the value of the standard deviation (SD) was 
calculated. Also, the difference (R) between the 
calculated dose (Dc) and mean measured dose 
(
_
Dm) was calculated using formula (1):
R =( 
_
Dm_Dc )· 100% (1)
          
Dc
The results of the calculated and measured dos-
es, shown in Table 2, were analyzed using statis-
tical methods. The ﬁ nal results of the statistical 
veriﬁ cation of calculated (Dc) and measured (
_
Dm) 
doses are shown in Table 3. Wilcoxon test and 
sign test were used. Calculated p-value was ana-
lyzed with conﬁ dence level a=0.05.
On the basis of tests carried out, no statistically 
signiﬁ cant differences between calculated and 
measured doses were afﬁ rmed.
The image obtained from the exposure of radio-
chromic ﬁ lm to irradiation is shown in Figure 3. 
Figure 1. The tissue equivalent phantom used for dosimetric 
verifi cation of the dose distribution in PDR brachytherapy.
Figure 2. Verifi cation of images from the Integrated Brachytherapy 
Unit (IBU).
Reference points
Measured doses [Gy]
Dm1 Dm2 Dm3 Dm4
P1 8.46 8.50 8.54 9.03
P2 34.12 32.49 32.90 30.33
P3 32.80 31.45 30.03 29.22
P4 – 9.29 9.00 8.61
P5 35.97 34.65 29.44 31.18
P6 39.26 35.11 34.07 33.23
P7 – 38.99 34.55 31.31
P8 33.29 31.52 29.41 26.55
P9 29.10 28.54 26.94 26.32
P10 21.65 20.67 18.03 17.94
P11 15.56 14.72 13.31 13.29
P12 24.03 23.29 19.48 19.23
P13 30.27 28.78 24.51 22.86
P14 25.93 25.54 21.24 21.10
Table 1. Doses from PDR brachytherapy treatment measured at 
14 reference points.
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The red circles mark the positions of two refer-
ence points (P1 and P2).
The dose distribution obtained after carrying 
out the analysis of MD-55 dosimetric ﬁ lms using 
the Origin application is shown in Figure 4. The 
red circles show the positions of two reference 
points (P1 and P2).
A fusion of two images was made: the image from 
the dosimetric ﬁ lms after digitalization and the 
dose distributions from the treatment planning 
Reference points
_
Dm [Gy] SD [Gy] Dc [Gy] ΔDc [Gy] R [%]
P1  8.63  0.26  10.08  0.50  –14.4
P2  32.46  1.58  29.76  1.49  9.1
P3  30.87  1.58  30.24  1.51  2.1
P4  8.97  0.34  10.51  0.53  –14.7
P5  32.81  3.02  31.53  1.58  4.1
P6  35.42  2.68  31.46  1.57  12.6
P7  34.95  3.85  32.22  1.61  8.5
P8  30.19  2.90  28.66  1.43  5.3
P9  27.72  1.31  25.86  1.29  7.2
P10  19.57  1.88  19.97  1.00  –2.0
P11  14.22  1.12  15.43  0.77  –7.8
P12  21.51  2.50  20.38  1.02  5.5
P13  26.61  3.49  25.64  1.28  3.8
P14  23.45  2.64  23.07  1.15  1.7
Table 2. Prescribed doses (Dc) and mean measured doses (
_
Dm) at 14 reference points and calculated statistical values – standard deviation 
(SD), calculation error (ΔDc), diff erence (R).
Reference points
Dc vs. Dm (p-value)
Wilcoxon Sign Test
P1 0.125 0.125
P2 0.125 0.125
P3 0.625 1.000
P4 0.250 0.250
P5 0.625 1.000
P6 0.125 0.125
P7 0.500 1.000
P8 0.375 0.625
P9 0.125 0.125
P10 0.625 1.000
P11 0.250 0.625
P12 0.625 1.000
P13 0.625 1.000
P14 0.625 1.000
Table 3. Calculated p-value for determined reference points for 
Wilcoxon test (column 2) and sign test (column 3).
Figure 3. Image obtained from the exposure GafChromic MD-55 
fi lm to radiation.
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system (Figure 5). The overlapping areas were re-
vealed. As a result it was afﬁ rmed that the calcu-
lation algorithms used by the Plato planning sys-
tem gives reliable dose distributions [7,8].
DISCUSSION
The author’s phantom made especially for this 
work was very useful. It simulated the patient, but 
could also be used for measurements using TLDs 
and GafChromic ﬁ lms. Commercially available 
phantom dose not support both kind of meas-
urements at the same time. The developed phan-
tom made it possible to position the TL detec-
tors in the places described by the authors. The 
phantom can be used for additional and other 
work in the future.
Using the phantom, 4 measurements were made 
at 14 reference points using thermoluminescent 
detectors. For each point the average value, the 
standard deviation and also the difference be-
tween the calculated and measured doses were 
calculated. On the basis of the measurement re-
sults, it was conﬁ rmed that the calculation algo-
rithm used by the Plato treatment planning sys-
tem works correctly [7,8,14,15]. It was found that 
there are no statistically signiﬁ cant differences be-
tween the calculated and measured doses. Some 
of the measurement points have occurred to the 
differences between doses measured and calculat-
ed. The high dose gradient area and the probabil-
ity of inaccurate positioning of TLD in the phan-
tom could have an inﬂ uence on the error.
For the qualitative analysis of the dose distribu-
tions obtained from the treatment planning sys-
tem and from the irradiation, radiochromic ﬁ lms 
were used [7,8,16]. GafChromic MD-55 ﬁ lm has 
several advantages – high spatial resolution, rel-
atively low spectral sensitivity, near tissue equiv-
alence – and it requires no special development 
procedure. Furthermore, it has low sensitivity 
to room light, which makes handling easy. The 
new ﬁ lms consist of double-layer radiochromic 
sensors dispersion coated on both sides of a pol-
yester base. The colourless and transparent ﬁ lm 
responds to ultraviolet light and to ionizing ra-
diation by turning blue. The overlapping areas 
have shown good agreement between both dose 
distributions. This also conﬁ rms that the calcu-
lation algorithm used by Plato leads to reliable 
dose distributions for PDR brachytherapy.
CONCLUSIONS
1. It was proved that the tissue equivalent phan-
tom designed by the authors was very useful for 
measurements using TLDs and GafChromic 
ﬁ lms in PDR brachytherapy.
2. On the basis of the dosimetric measurement 
results, it was conﬁ rmed that the calculation al-
gorithm used by the Plato treatment planning 
system works correctly. It was found that there 
Figure 4. Dose distribution obtained after the analysis of irradiated 
MD-55 dosimetric fi lms.
Figure 5. The fusion of two distributions from dosimetric fi lm 
digitalization and from treatment planning system.
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are no statistical signiﬁ cant differences between 
the calculated and measured doses.
3. On the basis of the qualitative analysis of the 
calculated and measured dose distributions, it 
was afﬁ rmed that the calculation algorithms 
used by the Plato planning system gives relia-
ble dose distributions.
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